Regulatory May 28, 2020 Nanoform Finland Plc har ansökt om upptagande till handel av dess aktier på Nasdaq First North Premier Growth Market Finland och Nasdaq First North Premier Growth Market Sweden
Regulatory May 28, 2020 Nanoform Finland Oyj on hakenut osakkeidensa listausta Nasdaq First North Premier Growth Market Finlandissa ja Nasdaq First North Premier Growth Market Swedenissä
Regulatory May 28, 2020 Nanoform Finland Plc has applied for its shares to be listed on Nasdaq First North Premier Growth Market Finland and Nasdaq First North Premier Growth Market Sweden
Regulatory May 25, 2020 Nanoform offentliggör en fast teckningskurs och publicerar ett prospekt för den planerade parallellnoteringen av dess aktier på Nasdaq First North Premier Growth Market i Finland & Sverige
Regulatory May 25, 2020 Nanoform julkistaa suunnitellun listautumisantinsa kiinteän merkintähinnan sekä esitteen liittyen kaksoislistautumiseensa Nasdaq First North Premier Growth Market -markkinapaikoille Suomessa ja Ruotsissa
Regulatory May 25, 2020 Nanoform announces a fixed subscription price and publishes a prospectus for its contemplated IPO and dual listing of its shares on Nasdaq First North Premier Growth Markets in Finland & Sweden
Regulatory May 11, 2020 Nanoform intends to launch an initial public offering and dual listing on Nasdaq First North Premier Growth Markets in Finland & Sweden
Regulatory May 11, 2020 Nanoform avser att genomföra ett erbjudande och att parallellnoteras på Nasdaq First North Premier Growth Market i Finland & Sverige
Regulatory May 11, 2020 Nanoform harkitsee listautumisantia ja kaksoislistautumista Nasdaq First North Premier Growth Market Finland ja Sweden -markkinapaikoille
Non Regulatory July 10, 2019 Nanoform appoints Director of Investor Relations following international growth
Non Regulatory May 30, 2019 Our CCO, Christian Jones, interviewed at EBD Group’s BIO-Europe Spring 2019.
Non Regulatory May 28, 2019 Nanoform accelerates growth with Director of Project Management appointment
Non Regulatory April 29, 2019 Nanoform strengthens GMP capabilities with Head of Manufacturing appointment
Non Regulatory January 14, 2019 Nanoform set to boost world-class nanonization services with appointment of Chief Technology Officer
Non Regulatory January 7, 2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment
Non Regulatory December 10, 2018 Nanoform continues rapid expansion with construction of GMP manufacturing plant
Non Regulatory October 29, 2018 Nanoform set to globalize its technology with appointment of a Chief Commercial Officer
Non Regulatory September 19, 2018 Nanoform set to transform drug development through €7 million investment in patented nanoparticle technology
